Status:
COMPLETED
Efficacy of Brisk Walking in Parkinson's Disease
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
Parkinson Disease
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
Parkinson's disease (PD) is the second most common neuro-degenerative disease in older people. Falls are common among people PD with the incidence rate up to 70% and have strong associations with the ...
Eligibility Criteria
Inclusion
- Parkinson disease diagnosed by neurologist with Hoehn \& Yahr stage 2 or 3
- Having a 30-meter walking ability
Exclusion
- Significant neurological condition (other than Parkinson's disease)
- Musculoskeletal conditions affecting gait, balance or upper limb functions
- Had received deep brain stimulation surgery
- Cognitive impairment with Montreal Cognitive Assessment score \<24
- Present with on-off motor fluctuations.
Key Trial Info
Start Date :
October 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04048291
Start Date
October 15 2018
End Date
February 28 2020
Last Update
August 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong Polytechnic University
Hong Kong, Nothing Selected, Hong Kong, 0000